Vaxcyte, Inc. - COMMON STOCK (PCVX)

Historical Holders from Q2 2020 to Q3 2025

Symbol
PCVX on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
130M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
141M
Holdings value
$5.09B
% of all portfolios
0.009%
Grand Portfolio weight change
0%
Number of holders
278
Number of buys
132
Number of sells
-146
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vaxcyte, Inc. - COMMON STOCK (PCVX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 10.1% +7.78% $414M $32.5M 13.1M +8.5% FMR LLC 29 Aug 2025
JANUS HENDERSON GROUP PLC 10.1% -11.8% $472M -$57.2M 13.1M -10.8% JANUS HENDERSON GROUP PLC 30 Sep 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $427M 13M RA Capital Management, L.P. 31 Mar 2025
BlackRock, Inc. 7.6% $323M 9.83M BlackRock, Inc. 31 Mar 2025
T. Rowe Price Investment Management, Inc. 6.4% $300M 8.32M T. Rowe Price Investment Management, Inc. 30 Sep 2025

Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 141M $5.09B -$217M $36.02 278
2025 Q2 147M $4.79B -$48.1M $32.51 292
2025 Q1 133M $5.02B -$42.9M $37.76 302
2024 Q4 141M $11.5B +$183M $81.86 318
2024 Q3 137M $15.6B +$1.5B $114.27 325
2024 Q2 123M $9.26B +$268M $75.51 264
2024 Q1 119M $8.13B +$1.12B $68.31 249
2023 Q4 103M $6.47B +$69M $62.80 223
2023 Q3 101M $5.17B +$77M $50.98 202
2023 Q2 100M $4.99B +$866M $49.94 194
2023 Q1 84.1M $3.15B +$160M $37.48 186
2022 Q4 81.6M $3.91B +$1.14B $47.95 197
2022 Q3 56.5M $1.36B +$122M $24.00 121
2022 Q2 51.4M $1.12B +$31.3M $21.76 103
2022 Q1 49.9M $1.2B +$69M $24.15 86
2021 Q4 44.7M $1.06B +$32M $23.79 84
2021 Q3 43.2M $1.1B -$196K $25.37 77
2021 Q2 43.2M $973M -$14.1M $22.51 74
2021 Q1 44M $869M +$26.5M $19.75 73
2020 Q4 42.3M $1.12B +$58.3M $26.57 83
2020 Q3 37.8M $1.86B +$104M $49.38 60
2020 Q2 36M $1.13B +$1.13B $31.61 38